The largest database of trusted experimental protocols

4 protocols using cd27 o323

1

Cryo-EM Study of Immunoproteasome Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human 20S immunoproteasome core sample was purchased from Boston Biochem. The human i-20s at a concentration of 1.5 mg per ml was incubated with PKS21004 dissolved in DMF with a molar ratio of 1:250 ratio for 1 h at 37 °C, then the mixture was diluted in 50 mM HEPES, pH 7.6, 100 mM NaCl and 1 mM dithiotreitol to a final concentration of 0.1 mg per mL for cryo-EM study. Antibodies used for flow cytometry are described as below (clone, company): CD3 (UCHT1, Biolegend), CD4 (OKT4, Biolegend), CD8 (SK1, Biolegend), CD11c (3.9, Biolegend), CD14 (RMO52, Beckman Coulter), CD16 (3G8, Biolegend), CD19 (HIB19, BD), CD38 (LS198–4–3, Beckman Coulter), CD27 (O323, eBioscience), IgD (IA6–2, eBioscience), HLA-DR (L243, Biolegend), Ki67 (Ki-67, Biolegend).
+ Open protocol
+ Expand
2

Murine and Human B-cell Antibody Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-murine Abs used in these studies include: B220 (RA3-6B2), CD24 (M1/69), CD21 (7E9), CD23 (B3B4), CD4 (RM4-4) and CD44 (IM7) from Biolegend; IgMa (DS-1) and CD40 (3/23) from BD; Ly 5.1 (A20), Ly 5.2 (104), Gr1 (RB6-8C5), CD11b (M1/70), CD3 (17A2), BAFFR (eBio7H22-E16), CD93 (AA4.1), CD62L (MEL-14) and CD40L (MR1) from eBiosciences; IgM (1B4B1) and IgD (11 (link)-26 (link)) from Southern Biotech; recombinant human insulin conjugated to biotin from Fitzgerald Industries; Streptavadin (S-868) from Life Technologies. Anti-human Abs used include: CD19 (HIB19) and IgM (MHM-88) from Biolegend; CD27 (O323) from eBiosciences; CD10 (HI10a), CD24 (ML5), CD38 (HIT2), IgD (IA6-2), and BAFFR (IIC1) from BD; anti–human FITC-conjugated 9G4 antibody (18 (link)).
+ Open protocol
+ Expand
3

CARMIL2-expressing T cell analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
We identified the T cell populations in which CARMIL2 reexpression occurred by staining PBMCs with the Abs against the following: CD3 (SK7), CD4 (SK3), CD8 (RPA-T8), CD25 (M-A251, all from BD), CD27 (O323; eBioscience), CD45RA (HI100, BD), CD56 (HCD56; Biolegend), FoxP3 (PCH101; eBioscience), and CARMIL2 (EM53; Exbio). Viability was assessed with Zombie Aqua Live/Dead stain (Biolegend). In patients with CARMIL2-expressing T cell populations, T lymphoblasts were generated by stimulating 106 PBMCs with 5 ng/ml PMA, 1 µM ionomycin, and 100 U/ml IL-2 for 2 d before further expansion for 8–16 d in complete RPMI 1640 supplemented with 100 U/ml IL-2. The T lymphoblasts were sorted with Abs against CD3 (SK7), CD4 (SK3), CD8 (RPA-T8, all from BD), and CARMIL2 (EM53; Exbio). DNA was extracted from the CARMIL2-expressing cell populations with the DNeasy Blood and Tissue kit (Qiagen), and reversion events were confirmed by Sanger sequencing.
+ Open protocol
+ Expand
4

Comprehensive Immunophenotyping of Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained as previously described [13] (link). We used monoclonal antibodies against the following antigens (clones shown in parentheses): CD45 (HI30), CD3 (HIT3a), CD4 (OKT4), CD8 (HIT8a), CD56 (N-CAM), CD27 (O323) and CD62L (Dreg 56) (eBioscience, San Diego, CA). Antibodies and isotype-matched controls were directly conjugated to either fluorescein isothiocyanate (FITC), phycoerythrin (PE), phycoerythrin- cyanine 7 (PE-Cy7), allophycocyanin (APC), Pacific Blue, Alexa Fluor 700, or biotin, with the biotinylated antibodies developed using streptavidin-phycoerythrin-cyanine 5 (SA-PE-Cy5). We assessed viability in all experiments using a Live/Dead Fixable Near-IR Dead Cell Stain Kit for 633 nm excitation (Invitrogen, Carlsbad, CA). Immediately after staining, cells were fixed and stored in staining buffer plus 2% paraformaldehyde; tubes were then stored at 4°C in a rack wrapped in aluminum foil until analyzed.
Experiments were performed on an LSR II flow cytometer (BD Bioscience, San Jose, CA), equipped with the following lasers: 488 nm blue, 405 nm violet laser, 633 nm red HeNe laser, and a 561 nm yellow-green laser. Data were collected using FACSDiva software (BD Biosciences) with automatic compensation and were analyzed using FlowJo software (Tree Star, Ashland, OR). We collected at least 10,000 viable CD45+ events per sample in each experiment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!